AC Immune SA
NASDAQ:ACIU
AC Immune SA
NASDAQ:ACIU
Price:
2.31 USD
-1.7%
Market Closed
Updated:
May 11, 2024
AC Immune SA
Operating Expenses
|
AC Immune SA
Operating Expenses Peer Comparison
Comparables:
ADCT
CRSP
BSLN
IDIA
KURN
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
AC Immune SA
NASDAQ:ACIU
|
Operating Expenses
-CHf68.4m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Operating Expenses
-$233m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Operating Expenses
-$593.7m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Operating Expenses
-CHf111.6m
|
CAGR 3-Years
4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-4%
|
|
|
Idorsia Ltd
SIX:IDIA
|
Operating Expenses
-CHf893.8m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
N/A
|
|
|
Kuros Biosciences AG
SIX:KURN
|
Operating Expenses
-CHf37.1m
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
See Also
What is AC Immune SA's Operating Expenses?
Operating Expenses
-68.4m
CHF
-68.4m
CHF
Based on the financial report for Dec 31, 2023, AC Immune SA's Operating Expenses amounts to -68.4m CHF.
What is AC Immune SA's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-4%
-4%
Over the last year, the Operating Expenses growth was 9%. The average annual Operating Expenses growth rates for AC Immune SA have been 4% over the past three years , -4% over the past five years .
You don't have any saved screeners yet
